Invention Grant
- Patent Title: Compositions and methods for weight loss in at risk patient populations
-
Application No.: US15725830Application Date: 2017-10-05
-
Publication No.: US10231964B2Publication Date: 2019-03-19
- Inventor: Preston Klassen , Kristin Taylor
- Applicant: Nalpropion Pharmaceuticals, Inc.
- Applicant Address: US NJ Morristown
- Assignee: Nalpropion Pharmaceuticals, Inc.
- Current Assignee: Nalpropion Pharmaceuticals, Inc.
- Current Assignee Address: US NJ Morristown
- Agency: Servilla Whitney LLC
- Main IPC: A61K31/485
- IPC: A61K31/485 ; A61P3/04 ; A61K31/137
Abstract:
The present disclosure relates to compositions, kits, uses, systems and methods related to naltrexone plus bupropion for treating an overweight or obese subject at increased risk of adverse cardiovascular outcomes. Preferably, the subject has had type-two diabetes for a period of less than 6 years or is a current smoker, optionally that does not have type-two diabetes.
Public/Granted literature
- US20180243288A1 COMPOSITIONS AND METHODS FOR WEIGHT LOSS IN AT RISK PATIENT POPULATIONS Public/Granted day:2018-08-30
Information query
IPC分类:
